Cepheid | coronavirus-portfolio

Antimicrobial Resistance (AMR)

Test Information

I am a:

${ profile.name.substring(0, profile.name.length - 1) }

Request Info

US-EUA

SARS-CoV-2 Portfolio

Xpert^® Xpress CoV-2 plus *

Designed with 3 gene targets for a rapid, robust detection of SARS-CoV-2.

Xpert^®Xpress CoV-2/Flu/RSV plus *

Offers a 3rd gene target to provide broader coverage to mitigate the possible effects of viral genetic drift.

Xpert^® Xpress SARS-CoV-2 *

Actionable, rapid respiratory results to meet the challenges of the ongoing pandemic.

Xpert^®Xpress SARS-CoV-2/Flu/RSV

Actionable rapid respiratory results to meet the challenges of the ongoing pandemic.

* For Emergency Use Authorization

Back to Top